Cargando…
Cotesting in Cervical Cancer Screening
Autores principales: | Malinowski, Douglas P, Broache, Molly, Vaughan, Laurence, Andrews, Jeff, Gary, Devin, Kaufman, Harvey W, Alagia, Damian P, Chen, Zhen, Onisko, Agnieszka, Austin, R Marshall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204934/ https://www.ncbi.nlm.nih.gov/pubmed/33270087 http://dx.doi.org/10.1093/ajcp/aqaa169 |
Ejemplares similares
-
Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States
por: Kaufman, Harvey W, et al.
Publicado: (2020) -
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019) -
Individualized Bayesian Risk Assessment for Cervical Squamous Neoplasia
por: Farchoukh, Lama F., et al.
Publicado: (2020) -
Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
por: Austin, R. Marshall, et al.
Publicado: (2020) -
How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling
por: Onisko, Agnieszka, et al.
Publicado: (2016)